Interview with CEO Per Håvard Kleven by the Norwegian Cancer Patient Association
Read the interview (only in Norwegian)
Skal hente opptil 20 millioner kroner
Article online
Skuddpremie på bivirkninger
PDF file
Experienced CEO joins Kongsberg Beam Technology
Kongsberg Hentet inn 13 millioner
Kreftceller i sikte
Studying medtech with cancer patients at heart
Article online
Semcon responsible for development of revolutionary cancer treatment
Article online
Fikk 22,7 millioner av Forskningsrådet
Skal drepe kreftceller mer effektivt med industriell ammunisjon
Article online